Cargando…
Metformin-induced metabolic reprogramming of chemoresistant ALDH(bright) breast cancer cells
Metabolic remodeling is a hallmark of cancer progression and may affect tumor chemoresistance. Here we investigated by 1H-NMR/PCA analysis the metabolic profile of chemoresistant breast cancer cell subpopulations (ALDH(bright) cells) and their response to metformin, a promising anticancer metabolic...
Autores principales: | Cioce, Mario, Valerio, MariaCristina, Casadei, Luca, Pulito, Claudio, Sacconi, Andrea, Mori, Federica, Biagioni, Francesca, Manetti, Cesare, Muti, Paola, Strano, Sabrina, Blandino, Giovanni |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4147311/ https://www.ncbi.nlm.nih.gov/pubmed/24980829 |
Ejemplares similares
-
MicroRNAs: short non-coding players in cancer chemoresistance
por: Donzelli, Sara, et al.
Publicado: (2014) -
Dropwort-induced metabolic reprogramming restrains YAP/TAZ/TEAD oncogenic axis in mesothelioma
por: Pulito, Claudio, et al.
Publicado: (2019) -
Metformin: Metabolic Rewiring Faces Tumor Heterogeneity
por: Cioce, Mario, et al.
Publicado: (2020) -
Metformin: On Ongoing Journey across Diabetes, Cancer Therapy and Prevention
por: Pulito, Claudio, et al.
Publicado: (2013) -
Cynara scolymus affects malignant pleural mesothelioma by promoting apoptosis and restraining invasion
por: Pulito, Claudio, et al.
Publicado: (2015)